A detailed history of Usa Financial Portformulas Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Usa Financial Portformulas Corp holds 91 shares of UTHR stock, worth $32,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Holding current value
$32,839
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$311.04 - $363.55 $28,304 - $33,083
91 New
91 $32,000
Q2 2023

Nov 27, 2023

SELL
$205.19 - $232.99 $3,488 - $3,960
-17 Reduced 6.97%
227 $50,000
Q1 2023

Nov 27, 2023

BUY
$212.99 - $276.17 $51,969 - $67,385
244 New
244 $54,000
Q3 2020

Oct 09, 2020

SELL
$99.9 - $121.13 $437,961 - $531,033
-4,384 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$92.74 - $125.82 $406,572 - $551,594
4,384 New
4,384 $530,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.